The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.5K Targets. Of those, 1.6M data for 765K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

46 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Cmpds
Data
Article Title
Organization
12
2-(3-Methoxyphenyl)quinazoline Derivatives: A New Class of Direct Constitutive Androstane Receptor (CAR) Agonists.EBI
Palacky University In Olomouc
5
Optimization of ADME Properties for Sulfonamides Leading to the Discovery of a T-Type Calcium Channel Blocker, ABT-639.EBI
Abbvie
9
Synthesis and biological evaluation of 2,3'-diindolylmethanes as agonists of aryl hydrocarbon receptor.EBI
University of Wisconsin
5
Bis-aryloxadiazoles as effective activators of the aryl hydrocarbon receptor.EBI
University of Utah
45
8-Benzamidochromen-4-one-2-carboxylic acids: potent and selective agonists for the orphan G protein-coupled receptor GPR35.EBI
University of Bonn
180
Three-dimensional quantitative structure-activity relationships from molecular similarity matrices and genetic neural networks. 2. Applications.EBI
Harvard University
118
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.EBI
University of Oxford
12
Targeting cytochrome P450 enzymes: a new approach in anti-cancer drug development.EBI
University of Maryland
63
3'-Substituted 7-halogenoindirubins, a new class of cell death inducing agents.EBI
Cnrs
39
Imidazo[1,5-a]quinoxalines as irreversible BTK inhibitors for the treatment of rheumatoid arthritis.EBI
Pfizer
28
Improvement in aqueous solubility in small molecule drug discovery programs by disruption of molecular planarity and symmetry.EBI
The University of Tokyo
9
beta-Naphthoflavone analogs as potent and soluble aryl hydrocarbon receptor agonists: improvement of solubility by disruption of molecular planarity.EBI
The University of Tokyo
1
Synthesis and biological properties of benzothiazole, benzoxazole, and chromen-4-one analogues of the potent antitumor agent 2-(3,4-dimethoxyphenyl)-5-fluorobenzothiazole (PMX 610, NSC 721648).EBI
Cardiff University
12
An overview of small-molecule agents for the treatment of psoriasis.EBI
Southern Medical University (The First People's Hospital of Shunde)
88
Discovery and optimisation of pyrazolo[1,5-a]pyrimidines as aryl hydrocarbon receptor antagonists.EBI
Latvian Institute of Organic Synthesis
20
Modulation of aryl hydrocarbon receptor activity by halogenated indoles.EBI
Palacky University
6
Novel Aryl Hydrocarbon Receptor Agonists for Treating Psoriasis and Atopic Dermatitis.EBI
Smith, Gambrell & Russell
2
A DNA Hypomethylation Signature Predicts Antitumor Activity of LSD1 Inhibitors in SCLC.EBI
Johns Hopkins University
19
A comprehensive review of new small molecule drugs approved by the FDA in 2022: Advance and prospect.EBI
Children's Hospital Affiliated to Zhengzhou University
6
Novel AHR Agonists for Treating Psoriasis and Atopic Dermatitis.EBI
Smith, Gambrell & Russell
3
Unraveling the Puzzle of Therapeutic Peptides: A Promising Frontier in Huntington's Disease Treatment.EBI
Aligarh Muslim University
6
Discovery of Natural Ah Receptor Antagonists from Salvia miltiorrhiza Bunge and Synthesis of Analogs for Tumor Immunotherapy.EBI
Chinese Academy of Medical Sciences and Peking Union Medical College
35
Discovery of 5-((1H-indazol-3-yl) methylene)-2-thioxoimidazolidin-4-one derivatives as a new class of AHR agonists with anti-psoriasis activity in a mouse model.EBI
Sichuan University
6
Novel AHR Agonists for Treating Psoriasis.EBI
Smith, Gambrell & Russell
6
Novel Aryl Hydrocarbon Receptor Agonists for Treating Psoriasis.EBI
Smith, Gambrell & Russell
25
An overview of aryl hydrocarbon receptor ligands in the Last two decades (2002-2022): A medicinal chemistry perspective.EBI
China Pharmaceutical University
12
2-substituted benzothiazoles as antiproliferative agents: Novel insights on structure-activity relationships.EBI
"G. d'Annunzio" University of Chieti-Pescara
4
Targeting the Aryl Hydrocarbon Receptor with Microbial Metabolite Mimics Alleviates Experimental Colitis in Mice.EBI
Palack£
39
Identification of triazolopyridine derivatives as a new class of AhR agonists and evaluation of anti-psoriasis effect in a mouse model.EBI
Sichuan University
1
The Highly Potent AhR Agonist Picoberin Modulates Hh-Dependent Osteoblast Differentiation.EBI
Max Planck Institute of Molecular Physiology
83
Structural modification aimed for improving solubility of lead compounds in early phase drug discovery.EBI
Indian Institute of Technology (B.H.U.)
1
An electrochemical device for the assay of the interaction between a dioxin receptor and its various ligands.EBI
Kyushu University
6
Indole scaffolds as a promising class of the aryl hydrocarbon receptor ligands.EBI
Palack£
31
Targeting the aryl hydrocarbon receptor with a novel set of triarylmethanes.EBI
Universitat De Val£Ncia. Av. Vicente Andr£S Estell£S
2
Synthesis and biological evaluation of FICZ analogues as agonists of aryl hydrocarbon receptor.EBI
University of Wisconsin-Madison
35
Development of Chemical Entities Endowed with Potent Fast-Killing Properties against EBI
Glaxosmithkline
5
Identification of new aryl hydrocarbon receptor (AhR) antagonists using a zebrafish model.EBI
Gwangju Institute of Science and Technology
8
Targeting Aryl hydrocarbon receptor for next-generation immunotherapies: Selective modulators (SAhRMs) versus rapidly metabolized ligands (RMAhRLs).EBI
University of Perugia
21
Potential Antiosteoporotic Natural Product Lead Compounds That Inhibit 17β-Hydroxysteroid Dehydrogenase Type 2.EBI
University of Basel
24
Synthesis and biological evaluation of pyrrole-based chalcones as CYP1 enzyme inhibitors, for possible prevention of cancer and overcoming cisplatin resistance.EBI
De Montfort University
10
Substituted bicyclic compoundsBDB
Bristol Myers Squibb
10
Cytotoxicity and topoisomerase I/II inhibition activity of novel 4-aryl/alkyl-1-(piperidin-4-yl)-carbonylthiosemicarbazides and 4-benzoylthiosemicarbazides.BDB
Medical University
41
Inhibitors of VEGF receptors-1 and -2 based on the 2-((pyridin-4-yl)ethyl)pyridine template.BDB
Chemical Diversity